Health Catalyst (HCAT) insider registers 20,838 restricted shares for sale

Rhea-AI Filing Summary

Health Catalyst, Inc. filed a Form 144 registering 20,838 shares of common stock for sale on 03/02/2026.

The filing identifies the broker Morgan Stanley Smith Barney LLC and lists the securities as restricted stock issued as compensation. The excerpt also reports prior restricted‑stock sales by Benjamin Landry of 14,387 shares on 12/01/2025, 27,425 shares on 12/05/2025, and 6,317 shares on 02/26/2026.

Insights

Equity Securities Counsel

Registration for resale of 20,838 restricted shares by an insider is procedural.

The filing lists 20,838 restricted shares to be sold on 03/02/2026 through Morgan Stanley Smith Barney LLC, with the shares described as compensation. This is a standard resale registration for restricted stock.

Cash‑flow treatment and whether proceeds go to the reporting person or another party are not stated in the excerpt; subsequent filings or broker disclosures would clarify settlement details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	20838	34589	70730884	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Restricted Stock	Health Catalyst, Inc.			20838	03/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Landry c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/01/2025	14387	41725.18
Benjamin Landry c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/05/2025	27425	72327.95
Benjamin Landry c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	02/26/2026	6317	11040.85

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Health Catalyst (HCAT) Form 144 show?

It registers 20,838 shares of restricted common stock for sale on 03/02/2026. The filing lists Morgan Stanley Smith Barney LLC as the broker and categorizes the shares as issued for compensation.

Who is the reporting person on the HCAT Form 144?

The excerpt names Benjamin Landry as the reporting person associated with the transactions. Prior restricted‑stock sales by him are recorded on 12/01/2025, 12/05/2025, and 02/26/2026.

How many shares did Benjamin Landry recently sell according to the filing?

The excerpt lists three past restricted‑stock sales: 14,387 shares on 12/01/2025, 27,425 shares on 12/05/2025, and 6,317 shares on 02/26/2026. These appear in the 'sold during the past 3 months' section.

Does the Form 144 state who receives the sale proceeds for HCAT shares?

The provided excerpt does not state the recipient of proceeds. It labels the securities as restricted stock issued for compensation, but cash‑flow treatment is not specified in the visible content.